Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Chemicals and Drugs (2)
- Medical Pharmacology (2)
- Neurosciences (2)
- Behavior and Behavior Mechanisms (1)
- Biochemical Phenomena, Metabolism, and Nutrition (1)
-
- Chemical Actions and Uses (1)
- Community Health and Preventive Medicine (1)
- Enzymes and Coenzymes (1)
- Genetic Processes (1)
- Medical Education (1)
- Medical Neurobiology (1)
- Mental Disorders (1)
- Mental and Social Health (1)
- Psychiatry and Psychology (1)
- Public Health (1)
- Substance Abuse and Addiction (1)
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Effects Of The Selective Gsk3b Inhibitor, Tideglusib, On Ethanol Consumption, Anxiety-Like Behavior, Taste Preference, And Downstream Proteins, Sam Gottlieb, Douglas Bledsoe, Jessica L. Maltman, Alanna Morgan, Jennifer T. Wolstenholme, Michael F. Miles
Effects Of The Selective Gsk3b Inhibitor, Tideglusib, On Ethanol Consumption, Anxiety-Like Behavior, Taste Preference, And Downstream Proteins, Sam Gottlieb, Douglas Bledsoe, Jessica L. Maltman, Alanna Morgan, Jennifer T. Wolstenholme, Michael F. Miles
Graduate Research Posters
Background: We have shown modulations in glycogen synthase kinase 3 beta (GSK3B) abundance or activity regulate ethanol consumption, suggesting potential as a therapeutic target for alcohol use disorder (AUD). Here we report the GSK3B inhibitor tideglusib’s actions on ethanol consumption, basal behaviors, and modulation of GSK3B targets.
Methods: C57BL/6J males and females received i.g. 200mg/kg tideglusib, except drinking-in-the-dark (males;100mg/kg i.p.). Drinking-in-the-dark (DID): Mice given 20% ethanol 4-hours, 4-days/week x 3 weeks and then i.p. tideglusib or vehicle x 4 days in a Latin Square design with ethanol consumption measured daily. Light/Dark Box: Mice gavaged with tideglusib or vehicle …
Selective Gsk3b Deletion In Camk2a+ Forebrain Neurons Or Inhibition Via Tideglusib, Decreases Ethanol Consumption In C57bl/6j Mice, Sam Gottlieb, Andrew D. Van Der Vaart, Brennen O'Rourke, Michael F. Miles
Selective Gsk3b Deletion In Camk2a+ Forebrain Neurons Or Inhibition Via Tideglusib, Decreases Ethanol Consumption In C57bl/6j Mice, Sam Gottlieb, Andrew D. Van Der Vaart, Brennen O'Rourke, Michael F. Miles
Graduate Research Posters
Purpose: We previously identified glycogen synthase kinase-3 beta (Gsk3b) as a central member of a gene network highly regulated by acute ethanol in medial prefrontal cortex (mPFC) and associated with risk for alcohol dependence in humans. Further, we have demonstrated modulation of Gsk3b alters ethanol consumption in rodent models. GSK3B could thus represent a potential new therapeutic target for the treatment of alcohol use disorder (AUD). Here, we investigate the mechanisms of Gsk3b action in ethanol consumption and report preclinical evidence for the selective GSK3B inhibitor, tideglusib, as a therapeutic agent for AUD.
Methods: (1) Selective Cre-induced Gsk3b …
The Metabolism Of Alcohol: Risk And Protective Factors, Sydney E. Levan, Amy Adkins, Danielle Dick, Karen G. Chartier
The Metabolism Of Alcohol: Risk And Protective Factors, Sydney E. Levan, Amy Adkins, Danielle Dick, Karen G. Chartier
Undergraduate Research Posters
Purpose: Abstract for poster submission to VCU Poster Symposium for
Undergraduate Research and Creativity
Title: The Metabolism of Alcohol: Risk and Protective Factors
Background: In 2002, it was reported by the National Institutes of Health that
60.3% of college aged students (18-22) drank alcohol in the past month of being
asked, as compared to 51.9% of those not in college. They also found that 20% of
college students met the criteria for at least one alcohol use disorder (AUDs)1.
Many genes have been linked to an increased risk for AUDs and how individuals
with various ethnic backgrounds respond to alcohol. …